Weight-loss drug Ozempic approved for use in India: Benefits, risks, price, and all you need to know about

Add DNA as a Preferred Source

General TRENDING NOW

In a major development for diabetes and weight loss management, India’s drug regulator, Central Drugs Standard Control Organisation (CDSCO), has approved Ozempic (semaglutide) for use in adults with type 2 diabetes. This means Danish drugmaker Novo Nordisk’s once-a-week injection will now be available in India on a doctor’s prescription, a significant step in a country often called the ‘diabetes capital of the world.’

General What is Ozempic?

Ozempic is the brand name for semaglutide, a medicine that helps regulate blood sugar in people with type 2 diabetes. First approved by the US FDA in 2017, it belongs to the class of GLP-1 receptor agonists and also supports weight management.

General Why is this approval important?

India is home to one of the largest populations of people with diabetes and obesity. Experts believe that access to advanced treatments like Ozempic will improve healthcare outcomes. Adding to the significance, Novo Nordisk’s patent for semaglutide expires in March 2026, paving the way for generic versions and making the drug more affordable in the near future.

General How does Ozempic work?

Ozempic mimics the action of the natural hormone GLP-1. It:

• Stimulates insulin release when blood sugar is high
• Reduces unnecessary glucagon secretion
• Slows gastric emptying, keeping patients fuller for longer
• Suppresses appetite, aiding in weight management

General Benefits of Ozempic

• Better blood sugar control for type 2 diabetics
• Effective weight loss when combined with diet and exercise
• Reduced cardiovascular risk, lowering chances of major heart issues

General Risks and side effects

While effective, Ozempic carries risks:

• Gastrointestinal issues like nausea, vomiting, and constipation
• Pancreatitis and gallbladder complications
• Kidney problems in some users
• Thyroid concerns
• Mood changes and anxiety, requiring medical supervision

General Celebrities who have used Ozempic

Ozempic has gained attention globally due to endorsements by celebrities like Elon Musk and Rebel Wilson. While many highlight its role in weight loss, experts caution against casual use without medical guidance.

General Price in India

The official Indian pricing of Ozempic is yet to be confirmed. However, according to a Hindustan Times report, its weight-loss version Wegovy may cost Rs 17,000-26,000 per month, depending on dosage, while rival drug Mounjaro (tirzepatide) is priced at Rs 14,000-17,500. Prices may vary by city, pharmacy, and packaging, and are expected to drop after generics launch post-2026.

Ozempic’s approval in India marks a new era in diabetes and weight management. While its benefits are significant, potential side effects highlight the need for doctor supervision and careful use. With generics on the horizon, this breakthrough treatment may soon become more accessible for millions of Indians.

Find your daily dose of All Latest News including Sports News, Entertainment News, Lifestyle News, explainers & more. Stay updated, Stay informed- Follow DNA on WhatsApp.